Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
  • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
  • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
  • A61K31/5375—1,4-Oxazines, e.g. morpholine
  • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
  • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
  • A61K31/445—Non condensed piperidines, e.g. piperocaine
  • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
  • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P35/00—Antineoplastic agents
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P35/00—Antineoplastic agents
  • A61P35/02—Antineoplastic agents specific for leukemia
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
  • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
  • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
  • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
  • C07D213/62—Oxygen or sulfur atoms
  • C07D213/63—One oxygen atom
  • C07D213/65—One oxygen atom attached in position 3 or 5
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
  • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
  • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

• Health & Medical Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• Medicinal Chemistry (AREA)
• Pharmacology & Pharmacy (AREA)
• Life Sciences & Earth Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• General Health & Medical Sciences (AREA)
• Epidemiology (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• General Chemical & Material Sciences (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Hematology (AREA)
• Oncology (AREA)
• Engineering & Computer Science (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Applications Claiming Priority (4)

Publications (1)

Family

ID=54936086

Family Applications (1)

Country Status (21)

Families Citing this family (27)

Family Cites Families (35)

• 2015
  • 2015-06-17 SG SG10201811128RA patent/SG10201811128RA/en unknown
  • 2015-06-17 CN CN202110532717.0A patent/CN113289022A/zh active Pending
  • 2015-06-17 EP EP23174369.1A patent/EP4252851A3/en active Pending
  • 2015-06-17 KR KR1020177000760A patent/KR102497728B1/ko active Active
  • 2015-06-17 IL IL309539A patent/IL309539A/en unknown
  • 2015-06-17 MX MX2021007651A patent/MX2021007651A/es unknown
  • 2015-06-17 PT PT158095406T patent/PT3157527T/pt unknown
  • 2015-06-17 EA EA201692285A patent/EA038337B1/ru unknown
  • 2015-06-17 SG SG11201610273VA patent/SG11201610273VA/en unknown
  • 2015-06-17 CA CA2952074A patent/CA2952074C/en active Active
  • 2015-06-17 AU AU2015277139A patent/AU2015277139A1/en not_active Abandoned
  • 2015-06-17 FI FIEP15809540.6T patent/FI3157527T3/fi active
  • 2015-06-17 CN CN201580036258.XA patent/CN106999498B/zh active Active
  • 2015-06-17 MX MX2016016744A patent/MX383866B/es unknown
  • 2015-06-17 ES ES15809540T patent/ES2948442T3/es active Active
  • 2015-06-17 DK DK15809540.6T patent/DK3157527T3/da active
  • 2015-06-17 IL IL285201A patent/IL285201B2/en unknown
  • 2015-06-17 JP JP2016573564A patent/JP6779793B2/ja active Active
  • 2015-06-17 SI SI201531951T patent/SI3157527T1/sl unknown
  • 2015-06-17 HU HUE15809540A patent/HUE062158T2/hu unknown
  • 2015-06-17 WO PCT/US2015/036310 patent/WO2015195848A1/en active Application Filing
  • 2015-06-17 PL PL15809540.6T patent/PL3157527T3/pl unknown
  • 2015-06-17 BR BR112016029492A patent/BR112016029492A2/pt not_active Application Discontinuation
  • 2015-06-17 US US15/319,535 patent/US10166238B2/en active Active
  • 2015-06-17 KR KR1020237004113A patent/KR20230031963A/ko not_active Ceased
  • 2015-06-17 EP EP15809540.6A patent/EP3157527B1/en active Active
  • 2015-06-17 LT LTEPPCT/US2015/036310T patent/LT3157527T/lt unknown
• 2016
  • 2016-12-07 IL IL249438A patent/IL249438A0/en unknown
• 2018
  • 2018-11-06 US US16/181,747 patent/US20190175604A1/en not_active Abandoned
• 2019
  • 2019-06-27 US US16/454,835 patent/US20200022987A1/en not_active Abandoned
• 2020
  • 2020-03-04 US US16/808,513 patent/US11642347B2/en active Active
  • 2020-09-28 AU AU2020244382A patent/AU2020244382B2/en active Active
• 2022
  • 2022-11-03 AU AU2022263523A patent/AU2022263523A1/en not_active Abandoned
• 2023
  • 2023-03-23 US US18/188,716 patent/US20240058348A1/en active Pending

Also Published As

Similar Documents